This competing continuation application requests funds to continue the Longitudinal Assessment of Manic Symptoms (LAMS) study at 4-sites. Over the past 3.5 years, using a valid and reliable screening instrument, children ages 6-12 years were identified with elevated symptoms of mania (ESM) at the time of their first clinical presentation. Approximately 621 youth were identified as having ESM. In addtion, 86 age/race/sex matched comparison children without ESM at first clinical presentation were enrolled. During the LAMS study, these participants were evaluated at baseline and every 6 months thereafter. At each assessment point, youths were evaluated regarding their psychiatric diagnoses, psychiatric symptomatology, mental health service utilization, and psychosocial functioning. As part of this competing continuation application (LAMS2), the investigators propose to continue these 6-month evaluations. In addition, LAMS2 will include both neurocognitive testing as well as neuroimaging techniques in order to identify possible biomarkers that reflect or are related to underlying biological mechanisms that predisopose individuals to the development of bipolar disorders. In acordance with the NIMH's Strategic Plan, LAMS2 would focus on examining and documenting trajectories of youths with ESM and related psychiatric disorders in order to better identify crucial timepoints for intervention. More specifically, the goals of LAMS2 include: 1) examining the stability of ESM over time in relation to changes in mood symptoms and DSM-IV-TR criteria for mood disorders;2) examining the positive predictive value of ESM alone and in combination with other potential risk factors in order to better identify youth who will eventually develop bipolar disorders (BPD) as they progress into and through adolescence;3) developing evidence-based, atheoretical, diagnostic criteria for a pediatric phenotype for bipolar spectrum disorders;4) identifying risk factors associated with poor functional outcomes for youth with ESM;5) examining the relationships between mood episodes and clinical outcomes over time;6) evaluating neurocognitive performance, together with functional abnormalities in selected neural systems and their relationship to ESM and the development of BPD during youth and early adulthood. The current participants will begin the competitive renewal period ranging in age from 8-17 years. At the end of LAMS2, June 2015, the cohort will range in years from 13-22 years. For this reason, LAMS 2 will provide an opportunity for the collection of innovative and clinically important data during a period of time in which when study participants will have entered an age of high risk for the development of a bipolar spectrum disorder.

Public Health Relevance

Diagnosing bipolar disorders (BPD) in youth is highly controversial. Goals of LAMS2 are to: 1) increase clarity of diagnosis (i.e., empirically delineate who does versus does not meet diagnostic criteria;develop evidence-based guidelines for diagnostic criteria in youth);2) improve understanding of risk and protective factors that propel high-risk youth into, or away from developing BPD;3) increase awareness of risk and protective factors that improve or detract from functional outcome for these youth;4) learn about the structural and functional brain abnormalities that occur in youth who do, versus do not, develop BPD over time.

National Institute of Health (NIH)
National Institute of Mental Health (NIMH)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-BBBP-L (60))
Program Officer
Avenevoli, Shelli A
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pittsburgh
Schools of Medicine
United States
Zip Code
Salcedo, Stephanie; Chen, Yen-Ling; Youngstrom, Eric A et al. (2018) Diagnostic Efficiency of the Child and Adolescent Symptom Inventory (CASI-4R) Depression Subscale for Identifying Youth Mood Disorders. J Clin Child Adolesc Psychol 47:832-846
Versace, A; Ladouceur, C D; Graur, S et al. (2018) Diffusion imaging markers of bipolar versus general psychopathology risk in youth at-risk. Neuropsychopharmacology 43:2212-2220
Van Meter, Anna R; You, Dokyoung S; Halverson, Tate et al. (2018) Diagnostic Efficiency of Caregiver Report on the SCARED for Identifying Youth Anxiety Disorders in Outpatient Settings. J Clin Child Adolesc Psychol 47:S161-S175
Hafeman, Danella M; Chase, Henry W; Monk, Kelly et al. (2018) Intrinsic functional connectivity correlates of person-level risk for bipolar disorder in offspring of affected parents. Neuropsychopharmacology :
Wise, T; Radua, J; Via, E et al. (2017) Common and distinct patterns of grey-matter volume alteration in major depression and bipolar disorder: evidence from voxel-based meta-analysis. Mol Psychiatry 22:1455-1463
Versace, Amelia; Sharma, Vinod; Bertocci, Michele A et al. (2017) Using machine learning and surface reconstruction to accurately differentiate different trajectories of mood and energy dysregulation in youth. PLoS One 12:e0180221
Ong, Mian-Li; Youngstrom, Eric A; Chua, Jesselyn Jia-Xin et al. (2017) Comparing the CASI-4R and the PGBI-10 M for Differentiating Bipolar Spectrum Disorders from Other Outpatient Diagnoses in Youth. J Abnorm Child Psychol 45:611-623
Hafeman, Danella; Bebko, Genna; Bertocci, Michele A et al. (2017) Amygdala-prefrontal cortical functional connectivity during implicit emotion processing differentiates youth with bipolar spectrum from youth with externalizing disorders. J Affect Disord 208:94-100
Jo, Booil; Findling, Robert L; Wang, Chen-Pin et al. (2017) Targeted use of growth mixture modeling: a learning perspective. Stat Med 36:671-686
Bertocci, Michele A; Bebko, Genna; Dwojak, Amanda et al. (2017) Longitudinal relationships among activity in attention redirection neural circuitry and symptom severity in youth. Biol Psychiatry Cogn Neurosci Neuroimaging 2:336-345

Showing the most recent 10 out of 57 publications